Muhammad Faiz Johan Arief1,2
Brandon Kar Meng Choo2
Jia Ling Yap2,3
Yatinesh Kumari2
Mohd Farooq Shaikh2*- 1MBBS Young Scholars Program, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
- 2Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
- 3School of Science, Monash University Malaysia, Bandar Sunway, Malaysia
Epilepsy is a common neurological disorder characterized by seizures which result in distinctive neurobiological and behavioral impairments. Not much is known about the causes of epilepsy, making it difficult to devise an effective cure for epilepsy. Moreover, clinical studies involving epileptogenesis and ictogenesis cannot be conducted in humans due to ethical reasons. As a result, animal models play a crucial role in the replication of epileptic seizures. In recent years, non-mammalian models have been given a primary focus in epilepsy research due to their advantages. This systematic review aims to summarize the importance of non-mammalian models in epilepsy research, such as in the screening of anti-convulsive compounds. The reason for this review is to integrate currently available information on the use and importance of non-mammalian models in epilepsy testing to aid in the planning of future studies as well as to provide an overview of the current state of this field. A PRISMA model was utilized and PubMed, Springer, ScienceDirect and SCOPUS were searched for articles published between January 2007 and November 2017. Fifty-one articles were finalized based on the inclusion/exclusion criteria and were discussed in this review. The results of this review demonstrated the current use of non-mammalian models in epilepsy research and reaffirmed their potential to supplement the typical rodent models of epilepsy in future research into both epileptogenesis and the treatment of epilepsy. This review also revealed a preference for zebrafish and fruit flies in lieu of other non-mammalian models, which is a shortcoming that should be corrected in future studies due to the great potential of these underutilized animal models.
Introduction
Epilepsy is a type of central nervous system (CNS) disorder that affects neuronal activity in the brain, causing unprovoked seizures and other behavioral changes (Mussulini et al., 2013). An abnormality in neuronal activity relates to excessive electrical discharges which results in seizure episodes that can vary in frequency from less than one per year to a few times per day. Seizures can be classified into two main types, partial seizures and generalized primary seizures. Furthermore, a seizure is divided into three stages: aura, ictus and postictal. The aura stage is experienced by the victim when he or she begins to display abnormal sensations such as nausea, headaches, abnormal senses and sudden emotions (fear, panic, etc.). The victim then enters the ictus stage in which the symptoms can be convulsive (vigorous jerking of the body and loss of consciousness) or non-convulsive (inability to respond and muscle spasms), depending on the type of seizure. The postictal stage is also known as the recovery stage and is when the victim begins to experience post-seizure symptoms such as drowsiness, confusion and partial paralysis. The onset of this disorder can occur in all ages, although it mostly occurs in childhood or later adulthood and is the fourth most common CNS disorder (England et al., 2012).
Currently around 70 million of the world's population is affected by epilepsy (Cunliffe et al., 2015). Epilepsies with known causes (secondary epilepsies) may be the result of prenatal brain damage, genetic abnormalities which lead to brain deformities, severe brain trauma, severe stroke, infection of the brain and brain tumors. Sufferers tend to have problems both physical (bruising and fractures from seizure) (Baker et al., 1997) and psychological (anxiety and depression) (Ettinger et al., 1998) in nature. The abnormal epileptic brain waves typical of epilepsy patients can be detected using the magnetoencephalography (MEG) and electroencephalogram (EEG) techniques (Karis, 2008). Unfortunately, epilepsy cannot be cured and can only be symptomatically treated. Treatment typically involves the usage of anti-epileptic drugs (AEDs) (White et al., 2007), surgery (Jette et al., 2014), vagus nerve stimulation (Uthman et al., 1993) or the ketogenic diet (Neal et al., 2008). However, about a third of the epileptic population do not respond to current epilepsy treatments (White et al., 2007). Moreover, epileptic individuals face a lower quality of life as they are burdened by the limitations placed on their physical activities and can be subjected to prejudice due to their disruptive seizures (Baker et al., 1997).
The usage of animal models is essential for the study of epilepsy as the process of epileptogenesis and ictogenesis cannot be induced in human trials due to ethical reasons. Rats and mice have previously been used for animal testing due to their similar morphological structure to humans. However, in recent years, non-mammalian epilepsy models have been the primary focus in animal testing due to multiple factors. These factors including increased cost-effectiveness, high genetic correlation with humans and rapid breeding, all of which improves the efficiency of epilepsy research (Cunliffe et al., 2015). In non-mammalian epilepsy models, Pentylenetetrazole (PTZ) (Kundap et al., 2017), kainic acid (KA) (Kandratavicius et al., 2014) and pilocarpine (PILO) (Kandratavicius et al., 2014) are among the proconvulsants used for stimulating seizures. In addition, electrical stimulation may also be used to induce seizures in animal models and differs from proconvulsants in that its effects can be studied without the continued presence of the epileptogenic cause (Kandratavicius et al., 2014). Thus, a comprehensive literature research was commenced to establish a systematic review which discusses the importance and usage of non-mammalian models in studies concerning epilepsy. This review aims to consolidate current information on the use and importance of non-mammalian models in epilepsy testing to better aid the planning of future research and screening of potential anticonvulsive compounds.
Materials and Methods
Search Method
Studies between January 2007 and November 2017 were considered for evaluation. This restriction is to ensure that the most recent publications are covered in this review while minimizing the possibility of inadvertently excluding older studies. An initial search of relevant studies was performed using Google Scholar to grasp the general scope of the topic. After that, a final search of relevant studies was conducted using several databases which were: PubMed, SCOPUS, SpringerLink and ScienceDirect. A search using the keywords “epilepsy,” “seizures,” “animal model,” and “convulsions” was first done to generate a list of relevant articles for each database. After that, the keywords “non-mammalian,” “drosophila,” “leech,” “planaria,” “roundworm,” “tadpole,” and “zebrafish” were searched for in each of the generated lists and used to select the final articles. This was done by first screening through the abstracts of the generated results, before proceeding to full text screening of potentially highly relevant articles.
Study Selection and Inclusion Criteria
Studies that were searched and considered for the systematic review were limited to original research articles as other publications (symposiums, conferences, editorials, book chapters, reviews and systematic reviews) would not provide sufficient information for evaluation and comparison. Any duplicated articles from the different databases were removed and articles that have no relevance to the importance of non-mammalian models for epilepsy research were also excluded. The selection of studies was conducted as per PRISMA guidelines (Moher et al., 2015).
Results
The initial search based on the keywords mentioned in the methodology yielded a total of 11,206 records. After applying exclusion criteria, total articles removed were 11,155, which includes; (a) 4,154 non-original research articles (b) 2,120 articles not related to animal models used in epilepsy research, (c) 306 duplicates, (d) 4,155 articles not related to non-mammalian models used in epilepsy research and (e) 420 full text articles not relevant to the aim of the review (Figure 1). Fifty-one eligible articles were included, compiled in Table 1 and discussed in the present systematic review. Based on the inclusion criteria, the final articles selected for evaluation consist of 19 articles relating to fruit flies, one article relating to leeches, three articles relating to planaria, two articles relating to roundworms, two articles relating to tadpoles and 24 articles relating to zebrafish, for a grand total of 51 articles. A brief overview of all the non-mammalian models for epilepsy research in our review is summarized in graphical form in Figure 2.
Figure 1. Flow chart of study selection criteria based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Table 1. Summary of the selected articles, together with high throughput screening feasibility.
Figure 2. A brief overview of all the non-mammalian models for epilepsy research in this review.
Fruit Fly (Drosophila melanogaster)
Drosophila have been widely used as a genetically tractable animal model for epilepsy research, especially the transgenic and mutant types. Seizures in Drosophila are defined as a period of brief leg twitches and is followed by a failure to maintain standing posture with leg shaking, abdominal muscle contractions, wing flapping and scissoring as well as proboscis extensions (Sun et al., 2012).
The usage of fruit fly models has been observed in 19 studies relating to epilepsy that were covered in this review.
Sleep Deprivation-Induced Seizures
Sleep and seizures have already been associated in humans as sleep deprivation is known to cause paroxysmal epileptiform activity (Lucey et al., 2015), though the exact mechanisms which relate the two together are currently unknown. Drosophila melanogaster is a powerful model organism that has been successfully used to study human physiologic processes such as sleep and disease states such as epilepsy (Shaw et al., 2000). Research into sleep and the fruit fly has shown that not only do flies sleep, but that data obtained in flies can be applied directly to humans (Lucey et al., 2015) as biomarkers of sleepiness first identified in the fruit fly have also been found to be elevated in healthy humans after a prolonged period of wakefulness (Seugnet et al., 2006). Drosophila mutants that are prone to mechanical and temperature induced seizures are a validated model to investigate the molecular and cellular networks responsible for seizure phenotypes (Burg and Wu, 2012) as mechanical and temperature stress-induced seizures exhibit several similar features to seizures in humans, such as a stereotyped behavioral sequence of spasm-and-paralysis, followed by a refractory period when the mutant flies are no longer sensitive to their respective stress disturbance (Lucey et al., 2015). The effects of sleep deprivation on seizure activity are not confined to a particular class of seizure mutant and can be observed using mechanical stimuli or changes in temperature to induce seizures (Lucey et al., 2015).
Effect of Cryptochrome-Dependent Magnetic Field on Seizure Response in Drosophila Larvae
Drosophila embryos exposed to pulsed blue light (470 nm) develop a heightened seizure-phenotype when tested post-embryonically at the third instar larvae stage, with the effect significantly potentiated when a magnetic field is also present (Marley et al., 2014). This is because the flavin adenine dinucleotide (FAD)-containing, circadian clock photoreceptor protein, cryptochrome (DmCRY) present in Drosophila central neurons, will render those neurons photosensitive and result in the increase in action potentials generated when illuminated with blue light (Fogle et al., 2011). The reason that magnetic fields potentiate the effect of blue light is that DmCRY plays a role in the magnetic sense of Drosophila (Gegear et al., 2010) and thus would also modulate the ability of light activated DmCRY to influence level of synaptic excitation in the Drosophila CNS.
Modeling Epilepsy Using Drosophila Mutants
Recent technical advances have now made it practical to readily target and replace endogenous sequences in the fly genome using homologous recombination (Rong and Golic, 2000; Rong et al., 2002; Staber et al., 2011). Knocking-in of specific disease-causing mutations into the fly genome could provide a rapid and low-cost platform for studying the cellular mechanisms of human diseases. Knock-in flies can be used in combination with forward genetic screens to identify suppressor and/or enhancer mutations, a strategy that is challenging in humans and rodent models but well established in Drosophila (Song et al., 2007, 2008). One example is the human SCN1A sodium channel gene, which has more than 600 possible mutations which can confer a wide spectrum of epilepsies (Claes et al., 2009; Lossin, 2009; Catterall et al., 2010). SCN1A has more than 40 missense mutations that are known to be linked to an epilepsy syndrome termed “genetic epilepsy with febrile seizures plus” (GEFS+) (Sun et al., 2012).
While undoubtedly there are many mutant strains of Drosophila useful for the modeling of epilepsy that have been and will be discovered, the bang-sensitive (BS) group of Drosophila mutants are perhaps more popular than others. BS flies are useful for modeling epilepsy as they are significantly more prone to seizure like activity from a variety of insults as compared to their wild type counterparts (Burns et al., 2004; Stone et al., 2013). In addition, the seizure like activity displayed by BS flies such as violent bursts of uncoordinated leg, wings and abdomen contractions that are interspersed with paralysis, have parallels to human epilepsy (Lee and Wu, 2002; Stone et al., 2013). This bodes well for the validity of the BS model of epilepsy and any subsequent translation of results to human studies.
Prickle proteins, which were first discovered in Drosophila, are highly conserved (Spencer, 1945). pksple1 mutants can be produced by crossing pksple1 homozygous mutants with yw67 control flies. pksple1 heterozygotes display none of the morphological abnormalities of the homozygotes but are significantly more bang sensitive than control flies of the same age. An epilepsy phenotype that is found in disparate species and crosses the invertebrate-vertebrate transition strongly suggests that the prickle proteins are part of a highly conserved evolutionary pathway for regulating seizures (Tao et al., 2011).
Brain Electrical Stimulation-Induced Seizures
As commonly seen in other models of epilepsy, electrical stimulation can also induce seizures in Drosophila (Song et al., 2007). This method essentially involves inserting electrodes into the Drosophila brain and delivering a certain amount of high frequency stimulation depending on their genotype, to induce seizures. The lowest possible intensity whereby seizures are elicited is known as the seizure threshold and if the flies fail to display seizures at the lowest possible intensity, the intensity is increased at 1V intervals until seizures are seen, with the fly being allowed to rest for several minutes in between each round of stimulation. Seizure activity in Drosophila is characterized by uncontrolled high frequency (> 100 Hz) neuronal firing and this can be most conveniently seen indirectly in the motor neurons that extensively innervate Drosophila thoracic muscle groups (Song et al., 2007; Kroll et al., 2015).
Drosophila Model of Refractory Epilepsy
The multidrug resistance-associated protein 1 (MRP1) is a member of the Adenosine Triphosphate (ATP) binding cassette (ABC) superfamily and is a transporter of organic anions and drugs. As MRP1 is typically found in the blood brain barrier of humans, it likely functions as a protective mechanism to prevent the build-up of xenobiotics and drugs in the brain. However, an overexpression of MRP1 would also lead to a decrease in the extracellular concentration of AEDs in the brain and thus lead to refractory epilepsy. Unsurprisingly, MRP1 has been found to be overexpressed in the neurons and astrocytes of patients with refractory epilepsy (Sun et al., 2016).
Drosophila mutants with sodium ion channelopathies, such as those with bss phenotypes, have a lower seizure threshold as compared to normal flies and are thus more prone to seizure episodes (Parker et al., 2011; Howlett et al., 2013). Seizures in bss flies are typically very difficult to supress using either suppressor mutations or AEDs, making them potential models of refractory epilepsy (Howlett et al., 2013). It is also possible to model human refractory epilepsy in Drosophila by causing an overexpression of human MRP1 in bss mutant flies. Such flies are resistant to the seizure attenuation effects of phenytoin (acute and chronic application) as well as valproic acid (chronic application) (Bao et al., 2011). Thus, bss mutant flies which overexpress human MRP1 have the potential to become a model of human refractory epilepsy.
Medicinal Leech (Hirudo verbena)
With the emergence of non-mammalian models for use in research, the potential benefits of the medicinal leech for epilepsy research was evaluated. Despite its uncommon usage in epilepsy studies, medicinal leeches possess a relatively simple CNS in terms of neuron count. This is further supported by the similar physiological processes found in both leech and mammalian nervous systems in terms of neural circuitry and development. The maintenance and handling of leeches is also simpler and inexpensive as compared to mammalian models (Hahn and Burrell, 2015).
Only one study by Hahn and Burrell (2015) was conducted using the medicinal leech as an animal model in this review. They did this by first placing a single leech in a 100 ml beaker filled with 50 ml of pond water. PTZ (10 mM) was then added and the resulting motor behaviors observed in the medicinal leeches were categorized into normal (1 and 2) and abnormal (3 and 4). The level of motor behavior was further categorized into different classes: Type 1 – no activity, Type 2 – normal exploratory behavior with posterior sucker attached to beaker, Type 3 – abnormal exploratory behavior coupled with an inability to attach to the beaker, Type 4 – spontaneous twisting and tumbling behavior. The results reveal that spontaneous behavioral movement occurred during PTZ bath application as PTZ induced a concentration-dependent increase in motor activity within 5 min of treatment. The heightened motor activity was maintained for the period of PTZ treatment before reducing to baseline levels during washout. The PTZ treatment induced almost entirely abnormal behavior but did not cause any lethal effects. Pretreating the leeches with 1 mM of the AED phenytoin for 30 min prior to the PTZ treatment reduced the level of abnormal behavior by causing a reduction in motor activity, as well as affecting the behavior score.
Planaria
Planaria are free-living non-parasitic flatworms of the phylum Platyhelminthes and possess a bilaterally symmetrical CNS composed of neurons similar to those of humans, a body plan common to all vertebrates and many invertebrates, as well as mammalian-like neurotransmitters (Rawls et al., 2009). Comparative genomic studies of invertebrate genomes such as the planarian Schmidtea mediterranea, with the human genome have identified gene and protein homologs, which portrays the fundamental principle that biochemical processes are comparable in simple and complex organisms (Ramakrishnan et al., 2013). Planarians have systems which correspond to all the major neurotransmission systems found in vertebrate brains, such as glutamate (excitatory) and GABA (inhibitory) (Ramakrishnan et al., 2013). Planarians also express the genes for at least two ionotropic glutamate receptor types, both of which have a high sequence similarity to neural specific genes isolated from both mice and humans. The effects of drugs acting on glutamatergic, serotoninergic, dopaminergic and cholinergic CNS neural transmission can also be examined in behavioral pharmacological studies involving planaria (Ramakrishnan and DeSaer, 2011). Invertebrate planaria also have the genes and neurotransmitters which correspond to the major inhibitory (GABA) and excitatory (glutamate) neurotransmission systems (Eriksson and Panula, 1994; Agata et al., 1998; Rawls et al., 2006). Even though these results suggest that glutamate-like receptors are important factors in planarian physiology, they are clearly not identical to mammalian glutamate receptors (Rawls et al., 2009). These differences in receptor homology and function may result in pharmacological effects that are not entirely the same across planarians and mammals. Nevertheless, planarian seizure models are easier to maintain and handle under laboratory conditions and are rather inexpensive in comparison with the other animal seizure models (Ramakrishnan and DeSaer, 2011), making planaria a fairly promising model for future research.
The usage of planaria models has been observed in three studies relating to epilepsy that were covered in this review.
Chemically Induced Seizures
Planaria exhibit sudden asynchronous convulsive movements which are very distinct from their normal locomotor activity, in proportion to the concentration of proconvulsant given (Ramakrishnan and DeSaer, 2011). D. tigrina exhibits screw-like hyperkinesis when exposed to 5 mM of picrotoxin. Planaria in the presence of low concentrations of (–)-nicotine (0.1 to 10 μM) display C-like and screw-like hyperkinesises whereas a more than 50 μM (–) of nicotine causes an increasing tendency to undergo longitudinal contraction, resulting in a walnut-like position. Once a planarian takes this walnut-like position, it essentially remains frozen in that position for a period of time (Ramakrishnan and DeSaer, 2011).
Nicotine, which is a cholinergic agonist, has also been found to induce hyperkinesia in planaria as neuronal nicotinic acetylcholine receptors (nAChR) play an excitatory role in the brain (Buttarelli et al., 2008). In addition, the molecular target for nicotine-induced seizures (α7 nAChR) was reported to be present in flatworms (Ribeiro et al., 2005). Planaria also exhibit seizure-like movements in nitrate and ammonia free tap water (Rawls et al., 2009). Dugesia dorotocephala has also been reported to display dose-dependent, seizure-like paroxysms when exposed to the excitatory neurotransmitters NMDA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and L-glutamate (Rawls et al., 2009).
Roundworms (Caenorhabditis elegans)
Caenorhabditis elegans (C. elegans) is emerging as an important model for furthering insight into the cellular and molecular basis of neurological disorders (Dexter et al., 2012; Alexander et al., 2014). This microscopic nematode has several physiological similarities to mammals such as possessing ion channels, neurotransmitters and a conserved neuron morphology. C. elegans is small, inexpensive to maintain and has a relatively short 3-day generation time, all of which make large scale screening feasible (Risley et al., 2016). Seizures in C. elegans are typically induced via electrical shock or by increasing the ambient temperature (Pandey et al., 2010; Risley et al., 2016). Alternatively, convulsions in C. elegans can also be induced by mutations in the lis-1-allele (pnm-1), a defect in γ-aminobutyric acid (GABA) transmission (unc-25 and unc-49 mutants) or by PTZ and RNAi treatments in roundworms with depleted LIS1 pathway compounds (NUD-1, NUD-2 and DHC-1, CDK-5, CDKA-1) (Pandey et al., 2010). In the case of genetic changes, the resulting seizures which are induced in C. elegans are taken to be repeated contractions in either the dorsal or ventral directions (Pandey et al., 2010).
The usage of roundworm models has been observed in two studies relating to epilepsy that were covered in this review.
Electroshock Assay for C. elegans
An electroshock assay similar to previously established convulsion models in fruit flies, was developed to quantitatively monitor paralysis duration and convulsions in C. elegans following electroshock. This method relies on the fact that young adult roundworms immediately exhibit paralysis with body stiffness and elongation following a brief three-second electric shock, though shocked animals resume normal movement after a short recovery period (Risley et al., 2016). As in mammals, the Maximal Electroshock Seizure Test (MEST) is the gold standard test for anticonvulsant activity (Risley et al., 2016).
High Temperature Assay for C. elegans
On the other hand, an increase in the surrounding temperature can cause abnormal bursts of neuronal cells which may be linked to seizures or convulsions (Pandey et al., 2010). Seizure index parameters were created by Pandey et al. (2010) as a way of quantify the convulsions in C. elegans. The seizure index is determined by placing the roundworms in a seizure promoting buffer (100 mM NaCl, 50 mM MgCl2) and then gradually increasing the temperature (26–28 ± 1°C) of the buffer using a variable intensity incandescent light source to generate heat. The seizures are ranked from 0 to 3, with 0 = no seizure or convulsion, 1(+) = two twitches in 10 s, 2(++) = two to five twitches in 10 s, 3(+++) = more than five twitches in 10 s or continuous twitching.
Tadpole (Xenopus laevis)
Tadpoles have been utilized as an animal model in a small number of epilepsy studies. They possess many traits that allow for the detailed analysis of their developing nervous systems to study disorders and neural development (Pratt and Khakhalin, 2013). Similar to zebrafish, tadpoles have a similar neural circuitry as compared to other vertebrates and is homologous to other mammals, yet simpler in design. The epileptiform discharges recorded from the optic tectum of tadpoles show similarity to those recorded in zebrafish and rodents (Bell et al., 2011; Pratt and Khakhalin, 2013). Their transparency also conveniently allows for in vivo imaging of neuronal activity and development as well as synaptogenesis (Hewapathirane et al., 2008) Their small size increases cost effectiveness as tadpoles are low maintenance due to their basic requirements. Thus, their neurological traits coupled with simpler maintenance, reinforces their role as an animal model in epilepsy research and an effective alternative to other animal models.
The usage of tadpole models has been observed in two studies relating to epilepsy that were covered in this review.
Behavioral Changes and Testing of Proconvulsants
A study relating to the in vivo imaging of seizure activity was conducted using a tadpole model. The tadpoles that were used in the study are transparent, which allows for the examination of seizure-induced effects on the developing brain. Five specific proconvulsants which include PTZ, picrotoxin (PTX), KA, pilocarpine and 4-aminopyridine (4-AP), were used to induce seizure behavior in the tadpoles (Hewapathirane et al., 2008; Bell et al., 2011). The first study discovered that all the proconvulsants tested can induce seizure behavior in tadpoles at different levels of severity. The following proconvulsants doses induced seizures within 20 min: PTZ (10–50 mM), PTX (1 mM), KA (0.25–1 mM), PILO (75 mM), 4-AP (0.5–2.5 mM). PTZ-induced seizures were given primary focus in ensuing experiments due to PTZ's dose range (10–50 mM) that rapidly causes severe seizures in the absence of toxic effects (Hewapathirane et al., 2008). Another study discusses the use of Xenopus tadpoles in examining the roles of polyamines in maintaining neural excitability. Bath application of 10 and 15 mM PTZ was used to induce seizures in tadpoles (Bell et al., 2011). Seizure behavior was observed after a few minutes exposed to PTZ and gradually increased, leading to loss of motor control (Bell et al., 2011). The seizure activity in both studies was characterized by directional control loss, immobility and C-shaped contractions.
In Vivo Electrophysiological Recordings
Xenopus tadpole models can also be used for electrophysiological recordings. In the first study, agar-immobilized tadpoles in a recording chamber were used to examine neuronal activity during proconvulsant-induced seizures, via extracellular field recordings (Hewapathirane et al., 2008). The recordings showed distinctive epileptiform discharges after exposure to different proconvulsants such as PTZ, PILO, 4-AP, and KA. The magnitude of epileptiform discharges gradually increases, eventually growing into high-amplitude spikes, in contrast to baseline recordings that are only comprised of sporadic low-amplitude spikes. The appearance of epileptiform discharges after proconvulsant washout varies based on the proconvulsant used. PILO (75 mM) induced spaced, sporadic high-amplitude epileptiform spiking (0.3 mV) whereas 4-AP (1 mM) caused sustained epileptiform discharges with a higher frequency. On the other hand, KA induced bursting in the form of fast-rhythmic spiking. Thus, it is possible to pinpoint the type of proconvulsant based on electrophysiological recordings using Xenopus tadpole models.
Analysis of Seizure-Related Cell Death
Two approaches were used to examine seizure-related cell death within the tadpole brain for the first study (Hewapathirane et al., 2008). One was the usage of fluorescein-based in situ terminal uridine deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), which aimed to detect DNA fragmentation related to cell apoptosis. The second method utilized the in vivo incorporation of propidium iodide (PI). The results revealed that a low number of TUNEL-positive sand PI-positive cells (assays) were present throughout control brains, which indicated a reduction in continuous cell loss during normal development. Cellular apoptosis due to prolonged seizures (4 h) failed to increase when measured by TUNEL labeling over a span of 6 h−2 days post-seizure. PI labeled cells slightly increased, which is indicative of abnormal cell membrane permeability mostly linked with necrotic cell death and sometimes cell apoptosis (Hewapathirane et al., 2008).
Zebrafish (Danio rerio)
Zebrafish have been acknowledged as one of the most widely-used animal models and have gained a reputation as an alternative to rodents and other animal models in epilepsy research over the last decade (Kundap et al., 2017). From a physiological perspective, they possess systems that are highly homologous to other vertebrates. The zebrafish genome has a 70% similarity to humans and zebrafish also possess complex anatomy and behavior which allows for the modeling of diseases (Cho et al., 2017). Both adult zebrafish and larvae can be used as animal models for epilepsy research, with larvae being the primary model in the majority of studies. Modification of gene and hence protein expression can be performed in zebrafish to produce genetically-modified zebrafish models by means of genetic intervention such as the injection of RNA, DNA and protein constructs during the early stages of embryo development (Berghmans et al., 2007). In contrast with rival models, zebrafish have lower maintenance costs and are capable of laying hundreds of eggs per week. Their complex behaviors and physiology allows for the modeling of diseases and mass drug screening (Cho et al., 2017). As a result, the increased utilization of zebrafish models in epilepsy research would present less economic issues to researchers.
Zebrafish have been used in 24 studies relating to epilepsy research that were covered in this review and are subdivided into the larval, adult and transgenic zebrafish subsections below.
Larval Zebrafish
Behavioral Changes
The evaluation of behavioral changes in zebrafish larvae treated with proconvulsants plays a huge role in the understanding of epilepsy and seizures. As zebrafish larvae only become free-swimming at 3 days post-fertilization (dpf), they can only then be clearly evaluated for behavioral changes (Hortopan et al., 2010b). The observed behavioral changes are evaluated from the aspects of locomotor activity and thigmotaxis (Berghmans et al., 2007; Yang et al., 2017). Seizure score systems have been devised to categorize seizures based on the criteria above (Berghmans et al., 2007; Hortopan et al., 2010b; Afrikanova et al., 2013), to provide a more objective way of evaluating behavioral changes. All zebrafish larvae tend to display a similar pattern of seizure progression, with signs of increased agitation within seconds of seizure induction, followed by increased locomotor activity and thigmotaxis soon thereafter. This behavior soon progresses into “whirlpool-like” swimming behavior and rapid swimming. Brief convulsions and loss of posture soon follows, as the larvae enters the advanced stages of a seizure. The final stage of a seizure is marked by a decrease in the distance traveled by the larvae as they experienced brief convulsions and loss of posture (Berghmans et al., 2007; Tiedeken and Ramsdell, 2007; Hortopan et al., 2010b; Lee et al., 2012; Afrikanova et al., 2013). At higher concentrations of proconvulsant, zebrafish larvae expire due to neural damage (Berghmans et al., 2007). Zebrafish larvae can also be tracked on multi-well plates for high-throughput screening of behavioral changes (Yang et al., 2017). These behavioral changes are similar to that in adult zebrafish, with slight differences. Some notable differences include increased seizure onset times, possibly due to relatively immature respiratory and nervous systems in larvae resulting in a slower proconvulsant absorption rate. The degree of seizure activity is also largely dependent on the concentration and type of proconvulsant (Berghmans et al., 2007; Yang et al., 2017). As in adults, behavioral changes in proconvulsant treated zebrafish larvae can also be influenced by dark-light environments (Yang et al., 2017).
Utilization of Proconvulsants
Zebrafish larvae provide a robust model that can be studied to understand the process of epileptogenesis through seizure induction using proconvulsants. In many of the studies, PTZ was primary proconvulsant used to induce seizures in zebrafish larvae. Other proconvulsants which have been used with zebrafish larvae include kainic acid, ginkgotoxin and picrotoxin (PTX) (Lee et al., 2012; Menezes et al., 2014; Yang et al., 2017). Proconvulsants are typically administered via bath application in multi-well plates, at different concentrations depending on the type of convulsant used. In majority of the studies covered, a 15–20 mM dose of PTZ was administered as these doses clearly produce all seizure scores in zebrafish larvae. Domoic acid (DA) can also be given to increase the seizure susceptibility of PTZ-treated zebrafish larvae by reducing the seizure threshold to produce an increase in locomotor activity (Lee et al., 2012).
PTX has also been used to induce seizures in other animal models (rodents and adult zebrafish) and causes significant increases in the locomotor activity of 5 dpf old zebrafish (Yang et al., 2017). Besides that, KA's efficacy in inducing seizure activity is dependent on the age of the zebrafish larvae as discovered by Menezes et al. (2014). These different results could be linked with state of the neural development in which the maturation of neurotransmitter systems influences the response to KA (Menezes et al., 2014). Similarly, ginkgotoxin at various concentrations (0.2–1 mM) causes hyperactive swimming in zebrafish larvae and also shows age dependent effects (Lee et al., 2012).
Screening of Anti-convulsive Compounds
Zebrafish larvae can also be used for the screening of anti-convulsive compounds by first pretreating them with the compound to be screened and then challenging them with a proconvulsant after a given habituation time. This screening method relies on the idea that if a compound is anti-convulsive, it should prevent or reduce the seizure behavior changes seen in proconvulsant treated zebrafish. Only microgram amounts of compound is required and can be quickly absorbed by zebrafish larvae through their gills, skin or gastrointestinal tract (Afrikanova et al., 2013). The small size of zebrafish larvae also allows it to thrive in small volumes, such as in the wells of a 96-well plate, which allows for the use of medium to high-throughput screening with an automated locomotor tracking system for the analysis of larval movement (Berghmans et al., 2007; Afrikanova et al., 2013). Prior to pretreatment, a toxicology evaluation may be performed to determine the maximum-tolerated concentrations (MTCs) of the drugs utilized, to avoid toxicity. This can be performed by using test compounds and observing the effects of AEDs on affected zebrafish for a period of 24 h (Barbalho et al., 2016).
Recording of Brain Electrical Activity
Another aspect of epilepsy research in zebrafish larvae is the tracking of brain electrical activity using EEG and by the evaluation of field potential. By tracking brain electrical activity, the epileptiform discharges that occur in proconvulsant treated zebrafish larvae and hence the number of seizure events that occur, can also be monitored (Afrikanova et al., 2013; Hunyadi et al., 2017; Turrini et al., 2017). The measurement of local field potential (LFP) in zebrafish larvae can also be performed by placing glass electrodes into their optic tectum (Afrikanova et al., 2013). Besides that, genetically-encoded calcium indicators (GCaMP6) have also been utilized as an optical method to track neuronal activity in zebrafish larvae (Turrini et al., 2017). This method is based on fluorescent calcium indicators and relies on the fact that there is a correlation between concentration of intracellular calcium and spiking frequency. Thus, it can be used to analyse seizure activity and to map zebrafish larvae brains. The peak amplitude of any recorded spikes is directly proportional to the concentration of proconvulsant used to induce seizures in the zebrafish larvae (Turrini et al., 2017). In another study, both invasive LFP and non-invasive LFP were utilized in zebrafish larvae to record local field potential and to determine the number of seizure events by interpreting the number of epileptic discharges (Hunyadi et al., 2017).
Adult Zebrafish
Behavioral Changes
The study of behavioral changes in adult zebrafish treated with proconvulsants is vital to epilepsy research. Behavior changes in adult zebrafish primarily involve its locomotor behavior. Aspects that are quantified in the evaluation of locomotor behavior include distance traveled, velocity, mobility, number of rotations and movement pattern of the zebrafish (Banote et al., 2013). Based on the severity of seizure activity, qualitative scoring systems were established to categorize zebrafish seizure activity into different scores (Pineda et al., 2011, 2013; Banote et al., 2013; Mussulini et al., 2013; Siebel et al., 2013; Gupta et al., 2014; Kundap et al., 2017; Choo et al., 2018). Initially, seizure activity begins with an increase in an adult zebrafish's swimming activity and is followed by short-burst, rapid swimming coupled with body jerking. Later stages of seizure activity are characterized by distinctive “whirl-pool” swimming behavior, clonic seizure-like behavior and loss of posture (Pineda et al., 2011; Mussulini et al., 2013). At a higher concentration of proconvulsant, zebrafish have a higher mortality rate due to the neural damage caused by epileptic seizures (Mussulini et al., 2013; Gupta et al., 2014). Severity of seizure activity and seizure latency are also largely dependent on the period of exposure to proconvulsant and the concentration of proconvulsant (Pineda et al., 2011; Mussulini et al., 2013; Siebel et al., 2013; Gupta et al., 2014). Other factors include gender differences, as demonstrated by one study which revealed that male zebrafish suffer more seizures than female zebrafish (Cho et al., 2017). In addition, the route of proconvulsant administration is also a factor as oral administration of proconvulsant elicits a seizure in adult zebrafish as quickly as bath application, but more weakly in terms of severity (Cho et al., 2017).
Utilization of Proconvulsants
When challenged with proconvulsants, adult zebrafish express seizure behavior which can be observed and analyzed. PTZ was utilized as a proconvulsant for many adult zebrafish studies in this review (Pineda et al., 2011, 2013; Banote et al., 2013; Mussulini et al., 2013; Siebel et al., 2013; Gupta et al., 2014; Cho et al., 2017; Duy et al., 2017; Kundap et al., 2017). Other types of proconvulsants such as KA (Sierra et al., 2012) were used to a lesser extent. Proconvulsants are typically administered through the oral, intraperitoneal (Sierra et al., 2012; Banote et al., 2013; Kundap et al., 2017) and bath application (Pineda et al., 2011, 2013; Mussulini et al., 2013; Siebel et al., 2013; Gupta et al., 2014; Cho et al., 2017) routes. Each route of administration produces a similar behavioral response, with different seizure onset times at different concentrations. In the studies covered, PTZ injections were done using concentrations ranging from 170 to 220 mg/kg, while PTZ bath applications used concentrations ranging from 2 to 15 mM (Sierra et al., 2012). The results obtained from multiple studies showed that PTZ at a lower concentration (<7.5 mM) induced minimal seizure activity in the first 5 min and more severe seizure activity in the last 15 min, whereas PTZ at a higher concentration (>7.5 mM) induced severe seizures in the first 5 min (Pineda et al., 2011; Mussulini et al., 2013; Gupta et al., 2014). On the other hand, KA at a concentration of 6 mg/kg induces seizures in adult zebrafish, 2.5 min post-intraperitoneal injection, which is entirely different that the typical elicitation of seizures using PTZ in other studies (Sierra et al., 2012). Another study utilized caffeine as a proconvulsant with concentrations ranging from 1–30 μM. The results of the study revealed that the higher the concentration of caffeine applied, the lower the latency of seizure onset in zebrafish (Gupta et al., 2014).
Screening of Anti-convulsive Compounds
Much like their larval counterparts, adult zebrafish can and have been utilized for the screening of anti-epileptic compounds. The method of doing so is essentially the same as in zebrafish larvae, but a key difference is that adult zebrafish are larger in size and thus would be more difficult to screen at high throughputs. Another difference is a larger ranger of administration routes such as intraperitoneal injections (Kundap et al., 2017), which may be impossible or very challenging to perform in larvae.
Recording of Brain Electrical Activity
The study of epilepsy in adult zebrafish also extends to the recording and evaluation of electrical activity within the brain. To track electrical activity within the brain of a zebrafish, an EEG may be used (Mussulini et al., 2013; Cho et al., 2017). Alternatively, an EEG equivalent for zebrafish would be the measurement of their cerebral field potential (Pineda et al., 2011, 2013; Banote et al., 2013). The long-term multichannel EEG utilizes a multichannel EEG electrode array for data acquisition. The two forms of seizure activity that can be recorded by an EEG are high-amplitude theta activities (5–7 Hz) which represent full-blown seizures similar as to TLE and low-frequency spike-wave activities which represent a an epilepsy discharge (2–3 Hz) (Cho et al., 2017). Similarly, other studies revealed high-amplitude sharp complexes in the measurement of the cephalic field potential in zebrafish, which is the result of seizure activity within the fish (Pineda et al., 2011, 2013; Banote et al., 2013). In addition, pre-treatment with AEDs resulted in a reduction in high-amplitude sharp complexes in PTZ-treated zebrafish, in a dose-dependent manner (Banote et al., 2013). It is further noted that continuous exposure to PTZ at 15 mM for 90 min resulted in a flat-line EEG, which is indicative of brain damage (Pineda et al., 2011; Mussulini et al., 2013).
Transgenic Zebrafish
Some studies have revealed that transgenic zebrafish models provide an efficient alternative to proconvulsants as they are more susceptible to seizures (Packer et al., 2016; Pena et al., 2017; Sourbron et al., 2017). Both transgenic adult and larvae models have been utilized in the studies covered.
Behavioral Changes
Behavioral changes in transgenic zebrafish models have been analyzed in certain studies, usually those relating to seizure activity and motor behavior (Packer et al., 2016; Pena et al., 2017; Sourbron et al., 2017). A zebrafish model of CLN3 disease or Batten's Disease was evaluated for seizure susceptibility, which revealed the first sign of motor abnormality at 36 h post-fertilization (hpf) whereby the CLN3 ATG morphants displayed higher movement activity and a higher number of tail flicks, both of which are indicative of seizure activity (Packer et al., 2016). Another study discussed the prospects of having a mutant scn1a gene be expressed in zebrafish as high levels of locomotor activity were observed in zebrafish scn1a mutants (Sourbron et al., 2017). The last study conducted presented aldh7a1 mutant zebrafish, with pyridoxine-dependent epilepsy (PDE) that showed signs of hyperactivity characterized by “whirlpool” swimming and loss of posture by 10 dpf when stimulated with light (Pena et al., 2017).
Seizure Susceptibility of Transgenic Models
The seizure susceptibility of transgenic models differs from each other to a certain degree and is influenced by external factors such as the presence of light and the age of the animal. For example, cln3 ATG mutants experience motor abnormalities at 36 hpf while aldh7a1 mutants experience motor abnormalities at 10 dpf. The aldh7a1 mutant is also affected by light stimuli, which appears to worsen the motor abnormality, causing “whirlpool” swimming activity and eventually loss of posture as it increases seizure susceptibility (Packer et al., 2016; Pena et al., 2017). Another study discusses the accumulation of piperideine 6-carboxylate (P6C), which can eventually lead to an increased seizure occurrence in affected zebrafish (Pena et al., 2017). An aldh7a1 mutation refers to PDE in which the seizure activity is dependent on levels of pyridoxine (Pyr). Aldh7a1 mutant larvae that were treated with Pyr have significantly suppressed seizure activity and daily treatment successfully prolonged their lives. The immediate withdrawal of Pyr treatment resulted in seizure activity and eventual death (Pena et al., 2017).
Electrographic Component of Induced Seizures Within Transgenic Models
The study of transgenic zebrafish models also extends to the tracking and evaluation of epileptiform electrographic activity. Once again, EEG was used for the recording of brain electrical activity. The field potential recordings acquired from both aldh7a1 mutants when stimulated with light, showed that the aldh7a1 mutant was suffering from spontaneous seizure activity which was marked by sudden bursts of high amplitude, long duration waves that were similar in appearance to the spontaneous seizure activity in other animal models. In comparison, wild type zebrafish had normal electric activity characterized by the absence of high amplitude waves (Pena et al., 2017). Similar results were also observed in a surface EEG conducted in using cln3 ATG MO morphants injected with p53 MO and ng cln3 ATG MO. Significantly higher amplitude waves with a frequency of 2–4 Hz was recorded, which reflects epileptiform activity (Packer et al., 2016). Sporadic multi-spike bursts which were similar to ictal-like waveforms were also recorded in 93% of mibhi904 zebrafish following exposure to 15 mM of PTZ (Hortopan et al., 2010a).
Discussion
Research using non-mammalian models of epilepsy offers substantial advantages for identifying and studying several seizure parameters including behavior, different types of cellular activities, electrophysiological changes and the genes involved in regulating seizures (Table 2). Though there are many insults that may be used to trigger seizure like behavior in the non-mammalian models of epilepsy, the behavioral changes that result are typically heightened motor activity. While these seizure behaviors can be measured qualitatively (the absence or presence of seizures), seizure scoring systems for the quantitative measurement of seizure behavior have also been designed for certain non-mammalian models such as zebrafish (Kundap et al., 2017) and roundworms (Pandey et al., 2010). Having a more finely grained method of scoring seizures could enable anti-epileptic compound screens to also detect compounds with less than ideal anti-epileptic activity in its unmodified form but could potentially become more potent after chemical modification. This is useful as even the first line AEDs being used today may not completely or permanently supress seizures at the more conservative doses usually preferred (Xia et al., 2017). However, care should be taken as the method of inducing seizures and the route of administration could potentially affect the animal in ways that may be directly observable (type and onset of behavioral changes) or otherwise (changes in neuronal activity).
Table 2. Characteristics, advantages, disadvantages, proconvulsants used with and the seizure behavior of the different non-mammalian models of epilepsy in this study.
Although the rodent seizure models continue to serve as the foundation for basic and translational epilepsy research, unconventional vertebrate (zebrafish) and invertebrate (fruit fly and roundworm) models are proving to have greater potential for analyzing the epilepsy phenotype as they are genetically tractable organisms (Baraban, 2007). As much regarding epilepsy is yet unknown, the ease of genetically modifying such organisms coupled with short generation times would greatly aid in identifying additional molecules, gene or signaling mechanisms which affect epileptogensis and epileptic behavior to better understand epilepsy. One possible use of genetically alterations is to produce mutant non-mammalian models of epilepsy which have different seizure thresholds. This would also aid understanding of the epilepsy phenotype by allowing researchers to mimic the clinical conditions of a wide variety of different epilepsy types. One day, it could even become possible to insert genes which confer seizure resistance into humans in the form of gene therapy to help ameliorate epilepsy, though there are many hurdles to overcome before that day arrives.
While the similarity of certain non-mammalian seizure like behaviors to human seizures (Lucey et al., 2015) is a great boon, the dissimilarity of these non-mammalian models to humans also ironically makes them ideal models. As an example, the non-mammalian models covered in this review typically have a relatively simpler CNS, yet retain much of the functionality and characteristics of their more complicated mammalian counterparts such as the major neurotransmission systems (Ramakrishnan et al., 2013) as well as neural circuitry and development (Hahn and Burrell, 2015). As the non-mammalian models covered in this review are relatively small, they can be easily and cheaply maintained in large numbers with little logistical and financial difficulties. Their small body size would also reduce the amount of chemicals such as proconvulsants and novel compounds that are needed for experimentation or screening, if they are available in limited quantities or are prohibitively expensive. In addition to their small size, the high breeding rate of some non-mammalian models also facilitates the use of high-throughput screening (Yang et al., 2017). When taken individually, it becomes clear that each non-mammalian model in this review has different characteristics, advantages, limitations and seizure behavior in response to different methods of inducing seizures.
The seizures induced in animal models typically mimic either human generalized or partial seizures. As mentioned previously, different seizure induction methods can be used to induced different seizures types. For example, MES can induce generalized tonic-clonic seizures whereas PTZ can induce non-convulsive generalized seizures (Löscher, 2011). That being said, it is worth noting that these seizure induction methods actually have poor face validity as the defining feature of epilepsy are the spontaneous recurrent seizures (Mussulini et al., 2013). However, the seizures induced by certain chemoconvulsants such as PTZ only cause transient acute seizures rather than true epilepsy. Nevertheless, the National Institute of Neurological Diseases and Stroke (NIH) actually recommends the use of PTZ and MES to induce acute seizures during the initial screening process (National Institute of Neurological Disorders and Stroke, 2013). This is likely an attempt to save both time and resources as although chronic seizure models using the proconvulsants kainic acid and pilocarpine which more closely mimic true human epilepsy exist, they require a significant investment in time and resources to carry out. That being said, the construct and predictive validity of acute seizure models is not entirely zero as compounds which show great anticonvulsive potential in such models would be more likely to also display that potential in true chronic models of epilepsy. The articles found in this review seem to support this belief, such as that by Kundap et al. (2017) who found that currently available anti-epileptic drugs which work in humans, also counteract PTZ induced seizures. It is also worth noting that although anti-epileptic drugs are so termed, they are actually anti-convulsants which only provide symptomatic treatment rather than treat the underlying cause of epilepsy.
With all the advantages of non-mammalian models over rodent models, one might wonder why rodent models remain so prolific? One of the reasons could be that rodents have been an established model since the days of old for their similarities to humans both anatomically and genetically as well as having a short reproductive cycle (Butterweck and Nahrstedt, 2012). Another reason for the widespread use of rodents, especially in the case of pharmacological safety and pharmacokinetic studies of potential novel drugs, is simple regulatory in nature. This is because drug regulatory agencies typically require the use of at least two mammalian species, including one non-rodent species, prior to the authorization of human trials (Atanasov et al., 2015). While the practice of using rodent models for epilepsy research no doubt arose from the cumulative work of our predecessors, perhaps it is time for a paradigm shift in the form of non-mammalian models. Rather than conducting preliminary studies using non-mammalian models before committing to rodent models for promising compounds, perhaps future pre-clinical epilepsy studies could be done solely in non-mammalian models and proceed directly to human trials if successful. This is supported by the findings that the disease-related genes in non-mammals such as zebrafish (84%) and drosophila (75%) have human orthologs (Pandey and Nichols, 2011; Kalueff et al., 2014). This coupled together with the human seizure like behavior and a higher effectiveness of non-mammalian models of epilepsy could 1 day allow them to replace rodent models of epilepsy instead of merely supplanting them. It is hoped that the information on the importance and usage of non-mammalian models in studies concerning epilepsy provided by this review will serve as a stepping stone for future research into the field of epilepsy and also the screening of anti-convulsive compounds.
Conclusion
In conclusion, non-mammalian models of epilepsy covered in this review have already shown great promise in the field of epilepsy research and the animals themselves offer many advantages over the typical mammalian rodent models of epilepsy. It is hoped that future research will take advantage of all these non-mammalian models of epilepsy as the tadpole, planarian, roundworms and medicinal leech models appear to be underutilized as compared to zebrafish and fruit flies, in terms of publication numbers. These models should not be discounted as researchers will need every possible tool at their disposal in the difficult quest to unravel the enigma that is epilepsy and possibly even discover a treatment for it 1 day.
Author Contributions
MJ and BC have joint first authorship for this publication. MJ and YL were responsible for the searching and screening of articles for this review. MJ, BC, and YL were responsible for the writing of the manuscript. MS was responsible for conceptualizing and revising the manuscript. YK was also involved in conceptualizing, proofreading and diagram preparation. All authors gave their final approval for the submission of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Afrikanova, T., Serruys, A. S., Buenafe, O. E., Clinckers, R., Smolders, I., De Witte, P., et al. (2013). Validation of the Zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs. PLoS ONE 8:e54166. doi: 10.1371/journal.pone.0054166
Agata, K., Soejima, Y., Kato, K., Kobayashi, C., Umesono, Y., and Watanabe, K. (1998). Structure of the Planarian Central Nervous System (CNS) revealed by neuronal cell markers. Zool. Sci. 15, 433–440. doi: 10.2108/zsj.15.433
Alexander, A. G., Marfil, V., and Li, C. (2014). Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. Front. Genet. 5:279. doi: 10.3389/fgene.2014.00279
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E. M., Linder, T., Wawrosch, C., Uhrin, P., et al. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33, 1582–1614. doi: 10.1016/j.biotechadv.2015.08.001
Baker, G. A., Jacoby, A., Buck, D., Stalgis, C., and Monnet, D. (1997). Quality of life of people with epilepsy: a European study. Epilepsia 38, 353–362. doi: 10.1111/j.1528-1157.1997.tb01128.x
Banote, R. K., Koutarapu, S., Chennubhotla, K. S., Chatti, K., and Kulkarni, P. (2013). Oral gabapentin suppresses pentylenetetrazole-induced seizure-like behavior and cephalic field potential in adult zebrafish. Epilepsy Behav. 27, 212–219. doi: 10.1016/j.yebeh.2013.01.018
Bao, G. S., Wang, W. A., Wang, T. Z., Huang, J. K., He, H., Liu, Z., et al. (2011). Overexpression of human MRP1 in neurons causes resistance to antiepileptic drugs in Drosophila seizure mutants. J. Neurogenet. 25, 201–206. doi: 10.3109/01677063.2011.620662
Baraban, S. C. (2007). Emerging epilepsy models: insights from mice, flies, worms and fish. Curr. Opin. Neurol. 20, 164–168. doi: 10.1097/WCO.0b013e328042bae0
Barbalho, P. G., Carvalho, B. S., Lopes-Cendes, I., and Maurer-Morelli, C. V. (2016). Cyclooxygenase-1 as a potential therapeutic target for seizure suppression: evidences from zebrafish pentylenetetrazole-seizure model. Front. Neurol. 7:200. doi: 10.3389/fneur.2016.00200
Bell, M. R., Belarde, J. A., Johnson, H. F., and Aizenman, C. D. (2011). A neuroprotective role for polyamines in a Xenopus tadpole model of epilepsy. Nat. Neurosci. 14, 505–512. doi: 10.1038/nn.2777
Berghmans, S., Hunt, J., Roach, A., and Goldsmith, P. (2007). Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res. 75, 18–28. doi: 10.1016/j.eplepsyres.2007.03.015
Burg, M. G., and Wu, C. F. (2012). Mechanical and temperature stressor-induced seizure-and-paralysis behaviors in Drosophila bang-sensitive mutants. J. Neurogenet. 26, 189–197. doi: 10.3109/01677063.2012.690011
Burns, R., Boyek, C., and Kuebler, D. (2004). “Carbon dioxide, high-frequency light pulses, and extreme temperature as triggers of seizure and paralysis in the bang-sensitive paralytic mutants,” in Annual Drosophila Research Conference (Washington, DC: Abstr C).
Buttarelli, F. R., Pellicano, C., and Pontieri, F. E. (2008). Neuropharmacology and behavior in planarians: translations to mammals. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 147, 399–408. doi: 10.1016/j.cbpc.2008.01.009
Butterweck, V., and Nahrstedt, A. (2012). What Is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med. 78, 747–754. doi: 10.1055/s-0031-1298434
Catterall, W. A., Kalume, F., and Oakley, J. C. (2010). NaV1.1 channels and epilepsy. J. Physiol. 588, 1849–1859. doi: 10.1113/jphysiol.2010.187484
Cho, S. J., Byun, D., Nam, T. S., Choi, S. Y., Lee, B. G., Kim, M. K., et al. (2017). Zebrafish as an animal model in epilepsy studies with multichannel EEG recordings. Sci. Rep. 7:3099. doi: 10.1038/s41598-017-03482-6
Choo, B. K. M., Kundap, U. P., Kumari, Y., Hue, S.-M., Othman, I., and Shaikh, M. F. (2018). Orthosiphon stamineus Leaf Extract Affects TNF-α and Seizures in a Zebrafish Model. Front. Pharmacol. 9:139. doi: 10.3389/fphar.2018.00139
Claes, L. R., Deprez, L., Suls, A., Baets, J., Smets, K., Van Dyck, T., et al. (2009). The SCN1A variant database: a novel research and diagnostic tool. Hum. Mutat. 30, E904–E920. doi: 10.1002/humu.21083
Cunliffe, V. T., Baines, R. A., Giachello, C. N., Lin, W. H., Morgan, A., Reuber, M., et al. (2015). Epilepsy research methods update: understanding the causes of epileptic seizures and identifying new treatments using non-mammalian model organisms. Seizure 24, 44–51. doi: 10.1016/j.seizure.2014.09.018
Dexter, P. M., Caldwell, K. A., and Caldwell, G. A. (2012). A Predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders. Neurotherapeutics 9, 393–404. doi: 10.1007/s13311-012-0109-x
Duy, P. Q., Berberoglu, M. A., Beattie, C. E., and Hall, C. W. (2017). Cellular responses to recurrent pentylenetetrazole-induced seizures in the adult zebrafish brain. Neuroscience 349, 118–127. doi: 10.1016/j.neuroscience.2017.02.032
England, M. J., Liverman, C. T., Schultz, A. M., and Strawbridge, L. M. (2012). Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav. 25, 266–276. doi: 10.1016/j.yebeh.2012.06.016
Eriksson, K. S., and Panula, P. (1994). Gamma-aminobutyric acid in the nervous system of a planarian. J. Comp. Neurol. 345, 528–536. doi: 10.1002/cne.903450405
Ettinger, A. B., Weisbrot, D. M., Nolan, E. E., Gadow, K. D., Vitale, S. A., Andriola, M. R., et al. (1998). Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39, 595–599. doi: 10.1111/j.1528-1157.1998.tb01427.x
Fogle, K. J., Parson, K. G., Dahm, N. A., and Holmes, T. C. (2011). CRYPTOCHROME is a blue-light sensor that regulates neuronal firing rate. Science 331, 1409–1413. doi: 10.1126/science.1199702
Gegear, R. J., Foley, L. E., Casselman, A., and Reppert, S. M. (2010). Animal cryptochromes mediate magnetoreception by an unconventional photochemical mechanism. Nature 463, 804–807. doi: 10.1038/nature08719
Gupta, P., Khobragade, S. B., and Shingatgeri, V. M. (2014). Effect of various antiepileptic drugs in zebrafish PTZ-seizure model. Indian J. Pharm. Sci. 76, 157–163. doi: 10.4103/0250-474X.131531
Hahn, E., and Burrell, B. (2015). Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech. Invert. Neurosci. 15:177. doi: 10.1007/s10158-014-0177-1
Hewapathirane, D. S., Dunfield, D., Yen, W., Chen, S., and Haas, K. (2008). In vivo imaging of seizure activity in a novel developmental seizure model. Exp. Neurol. 211, 480–488. doi: 10.1016/j.expneurol.2008.02.012
Hope, K. A., Ledoux, M. S., and Reiter, L. T. (2017). Glial overexpression of Dube3a causes seizures and synaptic impairments in Drosophila concomitant with down regulation of the Na+/K+ pump ATPa. Neurobiol. Dis. 108, 238–248. doi: 10.1016/j.nbd.2017.09.003
Hortopan, G. A., Dinday, M. T., and Baraban, S. C. (2010a). Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J. Neurosci. 30, 13718–13728. doi: 10.1523/JNEUROSCI.1887-10.2010
Hortopan, G. A., Dinday, M. T., and Baraban, S. C. (2010b). Zebrafish as a model for studying genetic aspects of epilepsy. Dis. Model Mech. 3, 144–148. doi: 10.1242/dmm.002139
Howlett, I. C., Rusan, Z. M., Parker, L., and Tanouye, M. A. (2013). Drosophila as a model for intractable epilepsy: gilgamesh suppresses seizures in para(bss1) heterozygote flies. G3 (Bethesda) 3, 1399–1407. doi: 10.1534/g3.113.006130
Howlett, I. C., and Tanouye, M. A. (2009). Neurocircuit assays for seizures in epilepsy mutants of Drosophila. J Vis Exp. e1121. doi: 10.3791/1121
Howlett, I. C., and Tanouye, M. A. (2013). Seizure-sensitivity in drosophila is ameliorated by dorsal vessel injection of the antiepileptic drug valproate. J. Neurogenet. 27, 143–150. doi: 10.3109/01677063.2013.817574
Hunyadi, B., Siekierska, A., Sourbron, J., Copmans, D., and De Witte, P. A. M. (2017). Automated analysis of brain activity for seizure detection in zebrafish models of epilepsy. J. Neurosci. Methods 287, 13–24. doi: 10.1016/j.jneumeth.2017.05.024
Jette, N., Reid, A. Y., and Wiebe, S. (2014). Surgical management of epilepsy. CMAJ 186, 997–1004. doi: 10.1503/cmaj.121291
Kalueff, A. V., Stewart, A. M., and Gerlai, R. (2014). Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 35, 63–75. doi: 10.1016/j.tips.2013.12.002
Kandratavicius, L., Balista, P. A., Lopes-Aguiar, C., Ruggiero, R. N., Umeoka, E. H., Garcia-Cairasco, N., et al. (2014). Animal models of epilepsy: use and limitations. Neuropsychiatr. Dis. Treat. 10, 1693–1705. doi: 10.2147/NDT.S50371
Kroll, J. R., Wong, K. G., Siddiqui, F. M., and Tanouye, M. A. (2015). Disruption of endocytosis with the dynamin mutant shibirets1 suppresses seizures in drosophila. Genetics 201, 1087–1102. doi: 10.1534/genetics.115.177600
Kundap, U. P., Kumari, Y., Othman, I., and Shaikh, M. F. (2017). Zebrafish as a model for epilepsy-induced cognitive dysfunction: a pharmacological, biochemical and behavioral approach. Front. Pharmacol. 8:515. doi: 10.3389/fphar.2017.00515
Lee, G. H., Sung, S. Y., Chang, W. N., Kao, T. T., Du, H. C., Hsiao, T. H., et al. (2012). Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5′-phosphate, GABA and anti-epileptic drugs. Dis. Model. Mech. 5, 785–795. doi: 10.1242/dmm.009449
Lee, J., and Wu, C. F. (2002). Electroconvulsive seizure behavior in Drosophila: analysis of the physiological repertoire underlying a stereotyped action pattern in bang-sensitive mutants. J. Neurosci. 22, 11065–11079. doi: 10.1523/JNEUROSCI.22-24-11065.2002
Li, J., O'leary, E. I., and Tanner, G. R. (2017). The ketogenic diet metabolite beta-hydroxybutyrate (β-HB) reduces incidence of seizure-like activity (SLA) in a Katp− and GABAb-dependent manner in a whole-animal Drosophila melanogaster model. Epilepsy Res. 133, 6–9. doi: 10.1016/j.eplepsyres.2017.04.003
Liu, R., Lin, S., Rallo, R., Zhao, Y., Damoiseaux, R., Xia, T., et al. (2012). Automated Phenotype recognition for zebrafish embryo based in vivo high throughput toxicity screening of engineered nano-materials. PLoS ONE 7:e35014. doi: 10.1371/journal.pone.0035014
Löscher, W. (2011). Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20, 359–368. doi: 10.1016/j.seizure.2011.01.003
Lossin, C. (2009). A catalog of SCN1A variants. Brain Develop. 31, 114–130. doi: 10.1016/j.braindev.2008.07.011
Lucey, B. P., Leahy, A., Rosas, R., and Shaw, P. J. (2015). A new model to study sleep deprivation-induced seizure. Sleep 38, 777–785. doi: 10.5665/sleep.4674
Marley, R., Giachello, C. N., Scrutton, N. S., Baines, R. A., and Jones, A. R. (2014). Cryptochrome-dependent magnetic field effect on seizure response in Drosophila larvae. Sci. Rep. 4:5799. doi: 10.1038/srep05799
Menezes, F. P., Rico, E. P., and Da Silva, R. S. (2014). Tolerance to seizure induced by kainic acid is produced in a specific period of zebrafish development. Prog. Neuropsychopharmacol. Biol. Psychiatry 55, 109–112. doi: 10.1016/j.pnpbp.2014.04.004
Mohammad, F., Singh, P., and Sharma, A. (2009). A drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs. BMC Syst. Biol. 3:11. doi: 10.1186/1752-0509-3-11
Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4:1. doi: 10.1186/2046-4053-4-1
Mussulini, B. H., Leite, C. E., Zenki, K. C., Moro, L., Baggio, S., Rico, E. P., et al. (2013). Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization. PLoS ONE 8:e54515. doi: 10.1371/journal.pone.0054515
Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., et al. (2008). The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7, 500–506. doi: 10.1016/S1474-4422(08)70092-9
National Institute of Neurological Disorders Stroke (2013). Models Currently in Active Use. Available online at: https://panache.ninds.nih.gov/CurrentModels.aspx (AccessedAugust 29, 2017).
O'reilly, L. P., Luke, C. J., Perlmutter, D. H., Silverman, G. A., and Pak, S. C. (2014). C. elegans in high-throughput drug discovery. Adv. Drug Delivery Rev. 69, 247–253. doi: 10.1016/j.addr.2013.12.001
Packer, R. M., Ortega, M., Anderson, T. J., Wager, K., Zdebik, A. A., Fu, S., et al. (2016). Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease). PLoS ONE 11:e0157365. doi: 10.1371/journal.pone.0157365
Pandey, R., Gupta, S., Tandon, S., Wolkenhauer, O., Vera, J., and Gupta, S. K. (2010). Baccoside A suppresses epileptic-like seizure/convulsion in Caenorhabditis elegans. Seizure 19, 439–442. doi: 10.1016/j.seizure.2010.06.005
Pandey, U. B., and Nichols, C. D. (2011). Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev. 63, 411–436. doi: 10.1124/pr.110.003293
Parker, L., Padilla, M., Du, Y., Dong, K., and Tanouye, M. A. (2011). Drosophila as a model for epilepsy: bss is a gain-of-function mutation in the para sodium channel gene that leads to seizures. Genetics 187, 523–534. doi: 10.1534/genetics.110.123299
Pena, I. A., Roussel, Y., Daniel, K., Mongeon, K., Johnstone, D., Mendes, H. W., et al. (2017). Pyridoxine-dependent epilepsy in zebrafish caused by Aldh7a1 deficiency. Genetics 207, 1501–1518. doi: 10.1534/genetics.117.300137
Pineda, R., Beattie, C. E., and Hall, C. W. (2011). Recording the adult zebrafish cerebral field potential during pentylenetetrazole seizures. J. Neurosci. Methods 200, 20–28. doi: 10.1016/j.jneumeth.2011.06.001
Pineda, R., Beattie, C. E., and Hall, C. W. (2013). Closed-loop neural stimulation for pentylenetetrazole-induced seizures in zebrafish. Dis. Model Mech. 6, 64–71. doi: 10.1242/dmm.009423
Pratt, K. G., and Khakhalin, A. S. (2013). Modeling human neurodevelopmental disorders in the Xenopus tadpole: from mechanisms to therapeutic targets. Dis. Models Mech. 6, 1057–1065. doi: 10.1242/dmm.012138
Ramakrishnan, L., Dalhoff, Z., Fettig, S. L., Eggerichs, M. R., Nelson, B. E., Shrestha, B., et al. (2013). Riluzole attenuates the effects of chemoconvulsants acting on glutamatergic and GABAergic neurotransmission in the planarian Dugesia tigrina. Eur. J. Pharmacol. 718, 493–501. doi: 10.1016/j.ejphar.2013.07.009
Ramakrishnan, L., and DeSaer, C. (2011). Carbamazepine inhibits distinct chemoconvulsant-induced seizure-like activity in Dugesia tigrina. Pharmacol. Biochem. Behav. 99, 665–670. doi: 10.1016/j.pbb.2011.06.003
Rawls, S. M., Gomez, T., Stagliano, G. W., and Raffa, R. B. (2006). Measurement of glutamate and aspartate in Planaria. J. Pharmacol. Toxicol. Methods 53, 291–295. doi: 10.1016/j.vascn.2005.10.004
Rawls, S. M., Thomas, T., Adeola, M., Patil, T., Raymondi, N., Poles, A., et al. (2009). Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol. Biochem. Behav. 93, 363–367. doi: 10.1016/j.pbb.2009.05.005
Ribeiro, P., El-Shehabi, F., and Patocka, N. (2005). Classical transmitters and their receptors in flatworms. Parasitology 131(Suppl.), S19–S40. doi: 10.1017/S0031182005008565
Risley, M. G., Kelly, S. P., Jia, K., Grill, B., and Dawson-Scully, K. (2016). Modulating Behavior in C. elegans using electroshock and antiepileptic drugs. PLoS ONE 11:e0163786. doi: 10.1371/journal.pone.0163786
Rong, Y. S., and Golic, K. G. (2000). Gene targeting by homologous recombination in Drosophila. Science 288, 2013–2018. doi: 10.1126/science.288.5473.2013
Rong, Y. S., Titen, S. W., Xie, H. B., Golic, M. M., Bastiani, M., Bandyopadhyay, P., et al. (2002). Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Develop. 16, 1568–1581. doi: 10.1101/gad.986602
Saras, A., and Tanouye, M. A. (2016). Mutations of the Calcium Channel Gene cacophony Suppress Seizures in Drosophila. PLoS Genet 12:e1005784. doi: 10.1371/journal.pgen.1005784
Seugnet, L., Boero, J., Gottschalk, L., Duntley, S. P., and Shaw, P. J. (2006). Identification of a biomarker for sleep drive in flies and humans. Proc. Natl. Acad. Sci. U.S.A. 103, 19913–19918. doi: 10.1073/pnas.0609463104
Shaw, P. J., Cirelli, C., Greenspan, R. J., and Tononi, G. (2000). Correlates of sleep and waking in Drosophila melanogaster. Science 287, 1834–1837. doi: 10.1126/science.287.5459.1834
Siebel, A. M., Piato, A. L., Schaefer, I. C., Nery, L. R., Bogo, M. R., and Bonan, C. D. (2013). Antiepileptic drugs prevent changes in adenosine deamination during acute seizure episodes in adult zebrafish. Pharmacol. Biochem. Behav. 104, 20–26. doi: 10.1016/j.pbb.2012.12.021
Sierra, S., Alfaro, J. M., Sánchez, S., and Burgos, J. S. (2012). Administration of docosahexaenoic acid before birth and until aging decreases kainate-induced seizures in adult zebrafish. Brain Res. Bull. 88, 467–470. doi: 10.1016/j.brainresbull.2012.04.007
Song, J., Hu, J., and Tanouye, M. (2007). Seizure suppression by top1 mutations in Drosophila. J. Neurosci. 27, 2927–2937. doi: 10.1523/JNEUROSCI.3944-06.2007
Song, J., Parker, L., Hormozi, L., and Tanouye, M. A. (2008). DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy. Neuroscience 156, 722–728. doi: 10.1016/j.neuroscience.2008.07.024
Sourbron, J., Smolders, I., de Witte, P., and Lagae, L. (2017). Pharmacological analysis of the anti-epileptic mechanisms of fenfluramine in scn1a mutant zebrafish. Front. Pharmacol. 8:191. doi: 10.3389/fphar.2017.00191
Spencer, W. P. (1945). A Study of Spontaneous Mutation. University of California Publications in Zoology, Volume 49, Number 10. Richard, B. Goldschmidt. The Quarterly Review of Biology 20, 380-381. doi: 10.1086/395005
Staber, C. J., Gell, S., Jepson, J. E., and Reenan, R. A. (2011). Perturbing A-to-I RNA editing using genetics and homologous recombination. Methods Mol. Biol. 718, 41–73. doi: 10.1007/978-1-61779-018-8_3
Stilwell, G. E., Saraswati, S., Littleton, J. T., and Chouinard, S.W. (2006). Development of a Drosophila seizure model for in vivo high-throughput drug screening. Eur. J. Neurosci. 24, 2211–2222. doi: 10.1111/j.1460-9568.2006.05075.x
Stone, B., Evans, L., Coleman, J., and Kuebler, D. (2013). Genetic and pharmacological manipulations that alter metabolism suppress seizure-like activity in Drosophila. Brain Res. 1496, 94–103. doi: 10.1016/j.brainres.2012.12.007
Streit, A. K., Fan, Y. N., Masullo, L., and Baines, R. A. (2016). Calcium imaging of neuronal activity in Drosophila can identify anticonvulsive compounds. PLoS ONE 11:e0148461. doi: 10.1371/journal.pone.0148461
Sun, L., Gilligan, J., Staber, C., Schutte, R. J., Nguyen, V., O'dowd, D. K., et al. (2012). A knock-in model of human epilepsy in Drosophila reveals a novel cellular mechanism associated with heat-induced seizure. J. Neurosci. 32, 14145–14155. doi: 10.1523/JNEUROSCI.2932-12.2012
Sun, Y., Luo, X., Yang, K., Sun, X., Li, X., Zhang, C., et al. (2016). Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies. Int. J. Neurosci. 126, 308–317. doi: 10.3109/00207454.2015.1015724
Tao, H., Manak, J. R., Sowers, L., Mei, X., Kiyonari, H., Abe, T., et al. (2011). Mutations in prickle orthologs cause seizures in flies, mice, and humans. Am. J. Hum. Genet. 88, 138–149. doi: 10.1016/j.ajhg.2010.12.012
Tiedeken, J. A., and Ramsdell, J. S. (2007). Embryonic exposure to domoic Acid increases the susceptibility of zebrafish larvae to the chemical convulsant pentylenetetrazole. Environ. Health Perspect. 115, 1547–1552. doi: 10.1289/ehp.10344
Turrini, L., Fornetto, C., Marchetto, G., Müllenbroich, M. C., Tiso, N., Vettori, A., et al. (2017). Optical mapping of neuronal activity during seizures in zebrafish. Sci. Rep. 7:3025. doi: 10.1038/s41598-017-03087-z
Uthman, B., Wilder, B., Penry, J., Dean, C., Ramsay, R., Reid, S., et al. (1993). Treatment of epilepsy by stimulation of the vagus nerve. Neurology 43, 1338–1338. doi: 10.1212/WNL.43.7.1338
Whelan, J., Burke, B., Rice, A., Tong, M., and Kuebler, D. (2010). Sensitivity to seizure-like activity in Drosophila following acute hypoxia and hypercapnia. Brain Res. 1316, 120–128. doi: 10.1016/j.brainres.2009.12.036
White, H. S., Smith, M. D., and Wilcox, K. S. (2007). Mechanisms of action of antiepileptic drugs. Int. Rev. Neurobiol. 81, 85–110. doi: 10.1016/S0074-7742(06)81006-8
Xia, L., Ou, S., and Pan, S. (2017). Initial response to antiepileptic drugs in patients with newly diagnosed epilepsy as a predictor of long-term outcome. Front. Neurol. 8:658. doi: 10.3389/fneur.2017.00658
Keywords: epilepsy, fruit fly, drosophila, leech, planaria, roundworm, tadpole, zebrafish
Citation: Johan Arief MF, Choo BKM, Yap JL, Kumari Y and Shaikh MF (2018) A Systematic Review on Non-mammalian Models in Epilepsy Research. Front. Pharmacol. 9:655. doi: 10.3389/fphar.2018.00655
Received: 19 April 2018; Accepted: 31 May 2018;
Published: 27 June 2018.
Edited by:
Francisco Lopez-Munoz, Universidad Camilo José Cela, SpainReviewed by:
Wladyslaw Lason, Institute of Pharmacology, Polish Academy of Sciences, PolandCarina Rodrigues Boeck, Centro Universitário Franciscano, Brazil
Copyright © 2018 Johan Arief, Choo, Yap, Kumari and Shaikh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mohd Farooq Shaikh, farooq.shaikh@monash.edu